RESEARCH: COVID-19
FOLDING PROJECT #16452 PROFILE

This project uses computer simulations to study NSP10, a protein crucial for the SARS-CoV-2 virus to function. By changing individual parts of NSP10, researchers can see how it affects its ability to activate other viral proteins needed for replication. This helps us understand how the virus works and could lead to new ways to stop its spread.

Note: This TLDR is a simplication and may not be 100% accurate.

This project is studying the NSP10 (Non-structural-protein-10) of SARS-CoV-2! In this project we are analyzing the role of _every_ single residue in NSP10 using a computational mutagenesis approach.

Each RUN in this project is simulating a unique mutant of NSP10, which we will compare to one another to identify critical residues of importance for NSP10 function.

NSP10 is an "activator" protein for critical viral function.

Two other proteins, NSP14, and NSP16 are important enzymes for viral function, but they both require NSP10 to bind them and "activate" them.

Without NSP10, these two enzymes would not function which would inhibit the virus from being able to replicate and transmit the infection COVID19.

This makes NSP10 an interesting potential biological target, as blocking its role as an activator could provide a therapeutic opportunity. However, it only participates in protein-protein interactions and does not have any obvious "pockets" or grooves amenable to targeting by drug design methods.

We are simulating NSP10 to identify potential druggable sites that have not been previously observed using experimental studies.

From a basic research standpoint, it will also be useful to understand how NSP10 actually "activates" its targets, as the mechanism of activation remains unknown.

---

NSP10

Non-structural protein 10

NSP10 is a viral protein found in SARS-CoV-2. It plays a crucial role in activating other viral proteins, NSP14 and NSP16, which are essential for viral replication and transmission. Due to its importance in viral function, NSP10 is considered a potential therapeutic target.

---

SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2

SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. It is a type of coronavirus that primarily affects the respiratory system.

---

Computational mutagenesis

A method of simulating mutations in a protein to study their effects on its function.

Computational mutagenesis uses computer simulations to introduce changes into a protein's sequence. By analyzing the effects of these changes on the protein's structure and function, researchers can gain insights into its mechanisms and identify potential drug targets.

---

Residue

A single amino acid in a protein chain.

Amino acids are the building blocks of proteins. Each amino acid has a specific chemical structure and properties. The sequence of amino acids in a protein determines its shape and function.

---

Protein-protein interaction

The binding of two protein molecules together.

Protein-protein interactions are essential for many biological processes. They allow proteins to work together in complex pathways and regulate cellular functions.

---

Drug design

The process of creating new drugs.

Drug design involves identifying potential drug targets and developing molecules that can bind to these targets and produce a desired therapeutic effect.

---

Therapeutic opportunity

A potential target for drug development.

A therapeutic opportunity arises when a specific biological pathway or molecule is identified as playing a role in a disease. This opens up the possibility of developing drugs that can modulate this pathway or molecule to treat the disease.